Keratinocyte-derived Chemokine in Obesity

Jaap G. Neels, Leylla Badeanlou, Kelly Hester, Fahumiya Samad

Journal of Biological Chemistry · 2009 · 74 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

Obese adipose tissue (AT) is associated with chronic inflammation, and we hypothesized that the keratinocyte-derived chemokine (KC), the mouse ortholog of human interleukin-8, plays a role in obesity-mediated AT inflammation and the subsequent manifestation of insulin resistance. KC expression is increased in the AT and plasma of genetically (ob/ob) and high fat diet-induced obese mouse models, and this increase may be mediated by the elevated leptin and tumor necrosis factor-α levels associated with obesity. Obesity-induced KC expression occurs primarily in stromal vascular cells and not in adipocytes, and it is high in preadipocytes and decreases during adipogenesis. Although KC has no effect on adipogenesis, it induces adipocyte expression of inflammatory factors and the insulin resistance mediator, suppressor of cytokine signaling 3. Using chimeric mice deficient in the KC receptor CXCR2 in their bone marrow, we show that the lack of CXCR2 in hematopoietic cells is sufficient to protect from adipose and skeletal muscle macrophage recruitment and development of insulin resistance in diet-induced obese mice. These studies suggest that KC and its receptor CXCR2 are potential targets for the development of new therapeutic approaches for treatment of obesity-related insulin resistance, type II diabetes, and related cardiovascular diseases. Obese adipose tissue (AT) is associated with chronic inflammation, and we hypothesized that the keratinocyte-derived chemokine (KC), the mouse ortholog of human interleukin-8, plays a role in obesity-mediated AT inflammation and the subsequent manifestation of insulin resistance. KC expression is increased in the AT and plasma of genetically (ob/ob) and high fat diet-induced obese mouse models, and this increase may be mediated by the elevated leptin and tumor necrosis factor-α levels associated with obesity. Obesity-induced KC expression occurs primarily in stromal vascular cells and not in adipocytes, and it is high in preadipocytes and decreases during adipogenesis. Although KC has no effect on adipogenesis, it induces adipocyte expression of inflammatory factors and the insulin resistance mediator, suppressor of cytokine signaling 3. Using chimeric mice deficient in the KC receptor CXCR2 in their bone marrow, we show that the lack of CXCR2 in hematopoietic cells is sufficient to protect from adipose and skeletal muscle macrophage recruitment and development of insulin resistance in diet-induced obese mice. These studies suggest that KC and its receptor CXCR2 are potential targets for the development of new therapeutic approaches for treatment of obesity-related insulin resistance, type II diabetes, and related cardiovascular diseases. Obesity is characterized by systemic low grade inflammation that appears to contribute to the genesis of insulin resistance (IR), 3The abbreviations used are: IRinsulin resistanceATadipose tissueKCkeratinocyte-derived chemokineILinterleukinDIOdiet-induced obeseTNF-αtumor necrosis factor-αSOCS3suppressor of cytokine signaling 3ATMAT macrophageWTwild typeNCnormal chowBMbone marrowGTTglucose tolerance testSVstromal vascularIRSinsulin receptor substrateHFDhigh fat dietBMTbone marrow transplantation. type 2 diabetes, and increased risk for cardiovascular diseases (reviewed in Ref. 1Pradhan A. Nutr. Rev. 2007; 65: S152-S156Crossref PubMed Google Scholar). Furthermore, adipose tissue (AT) produces a variety of inflammatory factors, and its excessive development in obesity is associated with accumulation of AT macrophages (ATMs) (1Pradhan A. Nutr. Rev. 2007; 65: S152-S156Crossref PubMed Google Scholar), whose recruitment and proinflammatory activation are required for the development of IR in obese mice (reviewed in Ref. 2de Luca C. Olefsky J.M. FEBS Lett. 2008; 582: 97-105Crossref PubMed Scopus (778) Google Scholar). An important question concerning ATMs is/are the trigger(s) driving the recruitment of these cells in obesity. insulin resistance adipose tissue keratinocyte-derived chemokine interleukin diet-induced obese tumor necrosis factor-α suppressor of cytokine signaling 3 AT macrophage wild type normal chow bone marrow glucose tolerance test stromal vascular insulin receptor substrate high fat diet bone marrow transplantation. Efforts at identifying factors that attract and recruit ATMs have mostly focused on the CC chemokine MCP-1 (monocyte chemoattractant protein-1) and its receptor CCR2. These studies have led to contradicting results with several publications showing that MCP-1 and CCR2 are important for ATM recruitment and the subsequent development of IR (3Kanda H. Tateya S. Tamori Y. Kotani K. Hiasa K. Kitazawa R. Kitazawa S. Miyachi H. Maeda S. Egashira K. Kasuga M. J. Clin. Invest. 2006; 116: 1494-1505Crossref PubMed Scopus (1999) Google Scholar, 4Weisberg S.P. Hunter D. Huber R. Lemieux J. Slaymaker S. Vaddi K. Charo I. Leibel R.L. Ferrante Jr., A.W. J. Clin. Invest. 2006; 116: 115-124Crossref PubMed Scopus (1271) Google Scholar, 5Kamei N. Tobe K. Suzuki R. Ohsugi M. Watanabe T. Kubota N. Ohtsuka-Kowatari N. Kumagai K. Sakamoto K. Kobayashi M. Yamauchi T. Ueki K. Oishi Y. Nishimura S. Manabe I. Hashimoto H. Ohnishi Y. Ogata H. Tokuyama K. Tsunoda M. Ide T. Murakami K. Nagai R. Kadowaki T. J. Biol. Chem. 2006; 281: 26602-26614Abstract Full Text Full Text PDF PubMed Scopus (690) Google Scholar), whereas others show no involvement of this chemokine and its receptor in these processes (6Chen A. Mumick S. Zhang C. Lamb J. Dai H. Weingarth D. Mudgett J. Chen H. MacNeil D.J. Reitman M.L. Qian S. Obes. Res. 2005; 13: 1311-1320Crossref PubMed Scopus (183) Google Scholar, 7Inouye K.E. Shi H. Howard J.K. Daly C.H. Lord G.M. Rollins B.J. Flier J.S. Diabetes. 2007; 56: 2242-2250Crossref PubMed Scopus (190) Google Scholar, 8Kirk E.A. Sagawa Z.K. McDonald T.O. O'Brien K.D. Heinecke J.W. Diabetes. 2008; 57: 1254-1261Crossref PubMed Scopus (113) Google Scholar). Furthermore, the studies that claim a role for MCP-1 and CCR2 in ATM recruitment and IR show that deficiency of the ligand or the receptor did not result in normalization of ATM content, indicating that other factors also participate in ATM recruitment. These findings suggest that the precise role of the MCP-1/CCR2 axis in ATM recruitment and IR is unclear, and that other chemokines and their receptors could also play a role in these processes. One such chemokine is interleukin 8 (IL-8), the prototypical CXC chemokine known to recruit and activate monocytes and to attract polymorphonuclear leukocytes to sites of inflammation (9Remick D.G. Crit. Care Med. 2005; 33: S466-S467Crossref PubMed Scopus (189) Google Scholar). IL-8 is elevated in plasma of obese subjects (10Straczkowski M. Dzienis-Straczkowska S. Stêpieñ A. Kowalska I. Szelachowska M. Kinalska I. J. Clin. Endocrinol. Metab. 2002; 87: 4602-4606Crossref PubMed Scopus (222) Google Scholar, 11Kim C.S. Park H.S. Kawada T. Kim J.H. Lim D. Hubbard N.E. Kwon B.S. Erickson K.L. Yu R. Int. J. Obes. 2006; 30: 1347-1355Crossref PubMed Scopus (373) Google Scholar) and correlates with adiposity and insulin sensitivity, suggesting an involvement of this chemokine in obesity-related health complications (12Bruun J.M. Verdich C. Toubro S. Astrup A. Richelsen B. Eur. J. Endocrinol. 2003; 148: 535-542Crossref PubMed Scopus (243) Google Scholar, 13Straczkowski M. Kowalska I. Nikolajuk A. Dzienis-Straczkowska S. Szelachowska M. Kinalska I. Cardiovasc. Diabetol. 2003; 2: 5Crossref PubMed Scopus (41) Google Scholar, 14Herder C. Haastert B. Müller-Scholze S. Koenig W. Thorand B. Holle R. Wichmann H.E. Scherbaum W.A. Martin S. Kolb H. Diabetes. 2005; 54: S11-S17Crossref PubMed Scopus (133) Google Scholar). Additionally, IL-8 is implicated in the pathogenesis of atherosclerosis and cardiovascular disease, two obesity-associated disorders (15Boisvert W.A. Curtiss L.K. Terkeltaub R.A. Immunol. Res. 2000; 21: 129-137Crossref PubMed Scopus (122) Google Scholar). Finally, IL-8 is an angiogenic factor, and angiogenesis is a hallmark of AT expansion in obesity (16Trayhurn P. Wood I.S. Br. J. Nutr. 2004; 92: 347-355Crossref PubMed Scopus (1744) Google Scholar). Although these findings suggest an important role for IL-8 in AT biology and pathology, little is known regarding the mechanism of regulation of IL-8 in obesity and its role in AT biology and pathology. This is probably due, in part, to the absence of suitable animal models because mice and rats do not have a clear-cut IL-8 ortholog (17Modi W.S. Yoshimura T. Mol. Biol. Evol. 1999; 16: 180-193Crossref PubMed Scopus (85) Google Scholar). Although rodent keratinocyte-derived chemokine (KC) shows the highest homology with human growth-related oncogene (GRO-α), it appears to be the closest equivalent to IL-8, as judged by its pattern of expression and putative function (18Watanabe K. Iida M. Takaishi K. Suzuki T. Hamada Y. Iizuka Y. Tsurufuji S. Eur. J. Biochem. 1993; 214: 267-270Crossref PubMed Scopus (78) Google Scholar). Monocytes express the KC receptor (CXCR2), and KC triggers monocyte arrest on early atherosclerotic endothelium, one of the first steps in the invasion of tissues by macrophages (19Huo Y. Weber C. Forlow S.B. Sperandio M. Thatte J. Mack M. Jung S. Littman D.R. Ley K. J. Clin. Invest. 2001; 108: 1307-1314Crossref PubMed Scopus (244) Google Scholar). Interaction of monocyte CXCR2 with its ligand KC leads to up-regulation of α4β1 integrin affinity and firm adhesion to the endothelium (19Huo Y. Weber C. Forlow S.B. Sperandio M. Thatte J. Mack M. Jung S. Littman D.R. Ley K. J. Clin. Invest. 2001; 108: 1307-1314Crossref PubMed Scopus (244) Google Scholar). Furthermore, both KC and its receptor play a central role in macrophage infiltration and accumulation in atherosclerotic lesions in mice (20Boisvert W.A. Santiago R. Curtiss L.K. Terkeltaub R.A. J. Clin. Invest. 1998; 101: 353-363Crossref PubMed Scopus (441) Google Scholar, 21Boisvert W.A. Rose D.M. Johnson K.A. Fuentes M.E. Lira S.A. Curtiss L.K. Terkeltaub R.A. Am. J. Pathol. 2006; 168: 1385-1395Abstract Full Text Full Text PDF PubMed Scopus (163) Google Scholar). However, no information is currently available regarding the role of KC in macrophage recruitment in obese AT or its role in AT biology and pathology. In this study, we show that KC expression is elevated in AT and plasma of genetically (ob/ob) and diet-induced obese (DIO) mice, probably as the result of increased leptin and tumor necrosis factor α (TNF-α) levels associated with obesity. We also show that obesity-induced KC is mostly derived from nonadipocyte sources in AT and that KC does not affect adipocyte differentiation but does increase pro-inflammatory cytokine expression in adipocytes. Finally, we show in a DIO model in chimeric mice lacking CXCR2 on their macrophages that the KC receptor plays an important role in macrophage accumulation in adipose and skeletal muscle tissue and subsequent development of IR. Animal studies were approved by our Institutional Animal Care and Use Committee and the Animal Research Committee, in accordance with Public Health Policy regarding the use and care of laboratory animals. Genetically obese mice deficient for leptin (C57BL/6J-Lepob; ob/ob), their respective lean counterparts (C57BL/6J WT), and CXCR2-deficient mice (C.129S2(B6)-Il8rbtm1MwmJ) and their appropriate WT controls (Balb/cJ) were from The Jackson Laboratories, Bar Harbor, ME. The p55−/−, p75−/−, and p55p75−/− mice were kindly provided by of Public In WT mice were with of or of leptin were with of AT and for the of the DIO or bone marrow mice were for on Research AT and bone marrow and glucose and insulin tolerance were as J. Clin. Invest. 2007; PubMed Scopus Google Scholar, C. W. S. A. M. Olefsky J.M. M. Metab. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). are available as mouse were from the These cells were and as H. Full Text PDF PubMed Scopus Google Scholar). In and were from the cells at to KC and In other cells were with or KC or the differentiation and or the differentiation KC 3 were at the cells were by with for and with as R.L. In Biol. 2002; PubMed Scopus Google Scholar). The from the cells with and the at expression were with or KC or for on of mouse fat are available as were the were from the AT of were from from were as C. W. S. A. M. Olefsky J.M. M. Metab. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). are available as of KC in plasma and were by an two by the several were by of and the Although KC is the of human IL-8, is increased in human obesity (10Straczkowski M. Dzienis-Straczkowska S. Stêpieñ A. Kowalska I. Szelachowska M. Kinalska I. J. Clin. Endocrinol. Metab. 2002; 87: 4602-4606Crossref PubMed Scopus (222) Google Scholar, 11Kim C.S. Park H.S. Kawada T. Kim J.H. Lim D. Hubbard N.E. Kwon B.S. Erickson K.L. Yu R. Int. J. Obes. 2006; 30: 1347-1355Crossref PubMed Scopus (373) Google Scholar), no information is available regarding the expression of KC in obese mice. We KC expression in genetically obese and DIO mice KC levels in AT from the genetically obese and DIO mice are and with their lean In KC in the plasma elevated by in and in DIO mice obesity is associated with and elevated levels of 2005; Full Text Full Text PDF PubMed Scopus Google Scholar), we or leptin the expression of KC in mice, with or an increase in AT KC levels by or The effect of leptin on KC expression is also from and the mice have a the DIO mice KC and levels are a role for leptin in KC However, the show that leptin is for the increased KC expression in obese mice, as is by the KC increase that in the mice. the of to the increase in KC we adipose tissue KC levels in and p75−/−, and lean mice, with or shows that results in an of KC levels in adipose tissue of and mice, but not in and p55p75−/− mice, that is a of KC expression in adipose tissue and that the receptor is for this these results show that AT KC expression and plasma levels of KC are increased in both genetically and diet-induced obese mice, probably as the result of the high levels of leptin and associated with obesity. we the sources for KC expression in obese and lean were to KC levels in both adipocyte and stromal vascular of AT from lean and obese (ob/ob) mice. in KC levels were in both and cells from lean suggesting that both are sources of However, in mice, KC expression in the adipocyte to that for lean adipocytes, its expression in the increased with lean mice. This that the increase in KC in the AT of obese mice is primarily to increased expression from cells the and not from adipocytes. The AT of and A. J. C. Clin. Endocrinol. Metab. 2007; PubMed Scopus Google Scholar). the expression of KC in preadipocytes and during adipocyte we an in model of KC expression high in preadipocytes and this expression during adipocyte to a in that in preadipocytes in KC expression in from preadipocytes express and this to in these in results show that KC is in preadipocytes and decreases during adipogenesis. studies have that the expression of and decreases during adipogenesis, to we for KC and These adipocyte differentiation R. Mol. Endocrinol. 2001; PubMed Scopus Google Scholar, P. D.J. 2003; PubMed Scopus Google Scholar, H. K.E. G.M. PubMed Scopus Google Scholar, J. S. J. K. S. T. H. N. PubMed Scopus Google Scholar), the that KC may also adipogenesis. We the effect of KC on chronic treatment of cells with or KC as by the lack of in the and of and of accumulation of the cells Although KC does not to affect and its expression is not increased in in obese AT we hypothesized that increased KC in obese AT by cells could affect the expression of inflammatory in adipocytes. in KC treatment of or for in a increase in expression of the inflammatory and but no in the and KC also the expression of a of insulin resistance J.K. Flier J.S. Endocrinol. Metab. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). These results suggest that the obesity-induced increase in AT KC expression may contribute to adipose inflammation the of proinflammatory in adipocytes. These with increased expression may to the development of insulin resistance. both KC and its receptor play a central role in macrophage infiltration and accumulation in atherosclerotic lesions in mice (20Boisvert W.A. Santiago R. Curtiss L.K. Terkeltaub R.A. J. Clin. Invest. 1998; 101: 353-363Crossref PubMed Scopus (441) Google Scholar, 21Boisvert W.A. Rose D.M. Johnson K.A. Fuentes M.E. Lira S.A. Curtiss L.K. Terkeltaub R.A. Am. J. Pathol. 2006; 168: 1385-1395Abstract Full Text Full Text PDF PubMed Scopus (163) Google Scholar), we hypothesized that the axis could play an important role in adipose tissue macrophage infiltration associated with obesity. We chimeric mice deficient in the KC receptor CXCR2 in their bone marrow as a in cells that were used as a of the of a normal chow diet and the other a the the this not by the 8 of of WT mice at at The of mice were at at the in both and and not not were the the and AT for the macrophage that macrophages the AT of the mice with WT mice and We results for not were in AT from the lean mice not The macrophages as H. J.W. J. Diabetes. 2007; 56: PubMed Scopus Google Scholar). of the adipocyte as a of adipocyte a increase in adipocyte in mice but no of the of as a of macrophage infiltration of the AT a in the mice with their WT counterparts We and others have that obesity is also associated with increased macrophage in skeletal muscle Olefsky J.M. D. C. B. S. M. J. Clin. Invest. 2007; PubMed Scopus Google Scholar, S. D. A. R. Olefsky J.M. J. Biol. Chem. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar, S.P. D. M. M. Leibel R.L. Ferrante Jr., A.W. J. Clin. Invest. 2003; PubMed Scopus Google Scholar, D. D. J. Olefsky J.M. Metab. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). we muscle levels of the macrophage in the expression of this is in mice with their WT its macrophages we the lack of CXCR2 on cells macrophage in the in expression levels in of mice did not from that of their WT these results that the lack of the KC receptor CXCR2 on cells has no effect on and adipocyte in a DIO mouse it results in a of macrophage infiltration of obese adipose and muscle a role for the in macrophage it has that macrophage recruitment and proinflammatory activation are required for the development of IR in obese mice (1Pradhan A. Nutr. Rev. 2007; 65: S152-S156Crossref PubMed Google Scholar), we insulin and glucose tolerance to the insulin in both WT and mice or glucose levels increased with in WT mice in in but not in mice in in Furthermore, insulin levels increased with in both WT and mice in in WT mice and in in mice, but were no in of insulin in mice in a in glucose levels of However, WT mice were to insulin and a in glucose In the mice the mice and a in glucose levels insulin We also a glucose tolerance test and obesity led to glucose in WT mice, whereas mice were Finally, the insulin during the increased by high fat but no were these results that mice are IR. The information on the expression and regulation of KC in AT of obese mice, and it a potential role for KC and its receptor CXCR2 in the inflammation, macrophage and insulin resistance associated with obesity. studies elevated KC expression in AT and plasma of obese mice are with has for IL-8 expression in human obesity J.M. S.B. Richelsen B. Am. J. Endocrinol. Metab. 2004; PubMed Scopus Google Scholar). KC in AT of obese mice to be derived primarily from to be preadipocytes with IL-8 expression in human obesity J.M. S.B. Richelsen B. Am. J. Endocrinol. Metab. 2004; PubMed Scopus Google Scholar). In obese the AT the and have systemic on other Luca C. Olefsky J.M. FEBS Lett. 2008; 582: 97-105Crossref PubMed Scopus (778) Google Scholar). increased adipose KC expression may contribute both to inflammation and to systemic increase in KC and may also contribute to the atherosclerosis associated with obesity. marrow from CXCR2-deficient mice that the lack of CXCR2 on bone cells results in a of obese adipose and muscle tissue macrophage Furthermore, the lack of CXCR2 on bone marrow cells also in identifying a role for this chemokine receptor not in the inflammation but also the subsequent manifestation of IR in obesity. be that CXCR2 affinity is associated with the of a in chemokines T.O. H. A. A. J. Immunol. 2000; PubMed Scopus Google Scholar). absence of CXCR2 not KC signaling but also the other of the CXC chemokine We the that the in in the mice are because of of signaling chemokines and not KC this C. S. C. I. J. J.S. J. C. H. R. A. M. B. R. A. A. A. D. Metab. Full Text Full Text PDF PubMed Scopus Google Scholar) a showing that KC ligand of is also in adipose is increased in and is by on of suggest that the of in adipose tissue are macrophages in the stromal vascular However, the use of and MCP-1 as for macrophages in the is because these are also in preadipocytes P. D.J. 2003; PubMed Scopus Google Scholar, J.M. N. J. Nutr. 2004; PubMed Scopus Google Scholar). the of macrophages and preadipocytes to both and KC expression by the stromal vascular to our of from insulin resistance in mice, C. S. C. I. J. J.S. J. C. H. R. A. M. B. R. A. A. A. D. Metab. Full Text Full Text PDF PubMed Scopus Google Scholar) show that CXCR2 mice are also obesity-induced IR. Although we did not in insulin levels C. S. C. I. J. J.S. J. C. H. R. A. M. B. R. A. A. A. D. Metab. Full Text Full Text PDF PubMed Scopus Google Scholar) an increase in insulin levels in their mice. This that the systemic of CXCR2 could also affect other and it may be that the increase in insulin the insulin levels in these C. S. C. I. J. J.S. J. C. H. R. A. M. B. R. A. A. A. D. Metab. Full Text Full Text PDF PubMed Scopus Google Scholar) suggest that increased expression by adipose tissue IR by of the insulin signaling to the CXCR2 receptor in muscle However, we also obesity-induced IR in our mice, and these are deficient for the receptor in their bone cells but have an CXCR2 receptor on their muscle on these we that the for obesity-induced IR in mice is not related to the that treatment IR in muscle but to the known role of CXCR2 and its in inflammation, as is by our on adipose and muscle tissue macrophage infiltration in mice. suggest that the of play central in the development of insulin resistance. the insulin receptor and its to insulin receptor and insulin signaling J.K. Flier J.S. Endocrinol. Metab. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). also insulin signaling by both and for J.K. Flier J.S. Endocrinol. Metab. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). studies showing that KC expression in an by the axis may to insulin resistance in the of obesity. this a showing that adipose tissue early in the of high fat A. N. R. J. Res. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). 3 and high fat were the of the adipose tissue but were at A. N. R. J. Res. 2008; Full Text Full Text PDF PubMed Scopus Google Scholar). KC is a chemoattractant for Y. Crit. Rev. Immunol. 2006; PubMed Google Scholar), it is not that KC and CXCR2 play an important role in this infiltration of adipose However, because we did not tissues at such early during the high fat of our mice, we could not regarding a potential role for CXCR2 in this This be a of studies have that proinflammatory and and chemokines and by and differentiation as as of R. Mol. Endocrinol. 2001; PubMed Scopus Google Scholar, P. D.J. 2003; PubMed Scopus Google Scholar, H. K.E. G.M. PubMed Scopus Google Scholar, J. S. J. K. S. T. H. N. PubMed Scopus Google Scholar). However, in our study, KC did not affect did it of as by and by the that KC treatment did not the expression of the and not also did not affect C. S. C. I. J. J.S. J. C. H. R. A. M. B. R. A. A. A. D. Metab. Full Text Full Text PDF PubMed Scopus Google Scholar). KC and to be with to their on adipogenesis. The of this In this that expression of the chemokine the IL-8 in is increased in plasma and adipose tissue of obese mice and that one or in the stromal vascular in the adipose tissues are for this increased We show that KC the expression of inflammatory factors and in and that the absence of its receptor CXCR2 on bone cells leads to a of macrophage infiltration of obese adipose and muscle tissue and from obesity-induced insulin resistance. These studies suggest that KC and its receptor CXCR2 are potential targets for the development of new therapeutic approaches for treatment of obesity-related insulin resistance and type II and related cardiovascular diseases. in the laboratory of D. J. by of Health with

References

36